Company
Headquarters: Jining, China
Employees: 6,170
CN¥9.61 Billion
CNY as of Jan. 1, 2026
US$1.37 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Shandong Lukang Pharmaceutical Co.,Ltd. manufactures and sells bio-pharmaceuticals and antibiotics in China. The company offers human and animal active pharmaceutical ingredients; human and animal preparations; bio-pesticides; herbal medicines; and amino acid. It is also involved in the sewage treatment, odor control, sewage facilities management, environmental protection material production and sale, and management of water disposal. The company exports its products to approximately 40 countries in Asia, Europe, Africa, and the United States. The company was formerly known as Jining Antibiotic Factory and changed its name to Shandong Lukang Pharmaceutical Co.,Ltd. in October 1993. Shandong Lukang Pharmaceutical Co.,Ltd. was founded in 1966 and is based in Jining, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥6.19 B |
| EBITDA | CN¥456.4 M |
| Gross Profit TTM | CN¥1.41 B |
| Profit Margin | 3.05% |
| Operating Margin | 7.87% |
| Quarterly Revenue Growth | 6.00% |
Shandong Lukang Pharmaceutical Co.,Ltd. has the following listings and related stock indices.
Stock: SSE: 600789